Tumour endothelial cells acquire drug resistance in a tumour microenvironment
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Tumour growth is dependent on angiogenesis, and tumour blood vessels are recognized as an important target for cancer therapy. Tumour endothelial cells (TECs) are the main targets of anti-angiogenic therapy. Unlike the traditionally held view, some TECs may be genetically abnormal and might acquire drug resistance. Therefore, we investigated the drug resistance of TECs and the mechanism by which it is acquired. TECs show resistance to paclitaxel through greater mRNA expression of multidrug resistance 1, which encodes P-glycoprotein, as compared with normal endothelial cells. We found that high levels of vascular endothelial growth factor in tumour-conditioned medium may be responsible for upregulated P-glycoprotein expression. This is a novel mechanism for the acquisition of drug resistance by TECs in a tumour microenvironment. This review focuses on the possibility that TECs can acquire drug resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Anti-VEGF therapies normalize the vasculature (69), which helps to provide efficient drug delivery, besides its anti-angiogenic effects.”
BackgroundCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 2×
“I Resistance in tumour cells Compensatory upregulation of several pro-angiogenic growth factors Casanovas et al. (18) Eikesdal and Kalluri (23) Vascular co-option Rubenstein et al. (24) Döme et al. (25) Leenders et al. (26) Transdifferentiation of tumour cells Ricci-Vitiani et al. (27) Wang et al. (28) Soda et al. (2…”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Johnson, D. H., Fehrenbacher, L., Novotny, W. F., Herbst, R. S., Nemunaitis, J. J., Jablons, D. M., Langer, C. J., DeVore, R. F., Gaudreault, J., Damico, L. A., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.022 · Cited by 1,937
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
Glioblastoma stem-like cells give rise to tumour endothelium
Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K. E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., & Tabar, V. (2010) · Nature · doi:10.1038/nature09624 · Cited by 1,203
Klement, G., Baruchel, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., & Kerbel, R. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8829 · Cited by 1,168
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
Kato, H., Ichinose, Y., Ohta, M., Hata, E., Tsubota, N., Tada, H., Watanabe, Y., Wada, H., Tsuboi, M., Hamajima, N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032792 · Cited by 818
Metronomic chemotherapy: new rationale for new directions
Pasquier, E., Kavallaris, M., & André, N. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.82 · Cited by 659
Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors
Shaked, Y., Ciarrocchi, A., Franco, M., Lee, C. R., Man, S., Cheung, A. M., Hicklin, D. J., Chaplin, D., Foster, F. S., Benezra, R., et al. (2006) · Science · doi:10.1126/science.1127592 · Cited by 570
Transdifferentiation of glioblastoma cells into vascular endothelial cells
Soda, Y., Marumoto, T., Friedmann-Morvinski, D., Soda, M., Liu, F., Michiue, H., Pastorino, S., Yang, M., Hoffman, R. M., Kesari, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016030108 · Cited by 515
Rubenstein, J. L., Kim, J., Ozawa, T., Zhang, M., Westphal, M., Deen, D. F., & Shuman, M. A. (2000) · Neoplasia · doi:10.1038/sj.neo.7900102 · Cited by 509
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., & Haga, N. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01345.x · Cited by 502
Tumor-Associated Endothelial Cells with Cytogenetic Abnormalities
Hida, K., Hida, Y., Amin, D. N., Flint, A. F., Panigrahy, D., Morton, C. C., & Klagsbrun, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1567 · Cited by 470
Self-citationKerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441
Genes that Distinguish Physiological and Pathological Angiogenesis
Seaman, S., Stevens, J., Yang, M. Y., Logsdon, D., Graff-Cherry, C., & St. Croix, B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.017 · Cited by 419
Ebos, J. M. L., Lee, C. R., Christensen, J. G., Mutsaers, A. J., & Kerbel, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708148104 · Cited by 367
An overview of small-molecule inhibitors of VEGFR signaling
Ivy, S. P., Wick, J. Y., & Kaufman, B. M. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.130 · Cited by 350
Functional involvement of P-glycoprotein in blood-brain barrier.
Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I., & Tsuruo, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88713-6 · Cited by 347
Liang, W.-C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., Fu, L., Malik, A. K., Gerber, H.-P., Ferrara, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508199200 · Cited by 346
Mi, Y.-J., Liang, Y.-J., Huang, H.-B., Zhao, H.-Y., Wu, C.-P., Wang, F., Tao, L.-Y., Zhang, C.-Z., Dai, C.-L., Tiwari, A. K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0111 · Cited by 337
Lymphoma-Specific Genetic Aberrations in Microvascular Endothelial Cells in B-Cell Lymphomas
Streubel, B., Chott, A., Huber, D., Exner, M., Jäger, U., Wagner, O., & Schwarzinger, I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033153 · Cited by 318
Sutherland, B. W., Kucab, J., Wu, J., Lee, C., Cheang, M. C. U., Yorida, E., Turbin, D., Dedhar, S., Nelson, C., Pollak, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208590 · Cited by 299
Altered angiogenesis and survival in human tumor‐derived endothelial cells
Bussolati, B., Deambrosis, I., Russo, S., Deregibus, M. C., & Camussi, G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0557fje · Cited by 288
Sathornsumetee, S., Cao, Y., Marcello, J. E., Herndon, J. E., McLendon, R. E., Desjardins, A., Friedman, H. S., Dewhirst, M. W., Vredenburgh, J. J., & Rich, J. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3652 · Cited by 261
Metronomic scheduling: the future of chemotherapy?
Gasparini, G. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00587-3 · Cited by 251
Kerbel, R. S., Yu, J., Tran, J., Man, S., Viloria-Petit, A., Klement, G., Coomber, B. L., & Rak, J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013172910858 · Cited by 237
Leenders, W. P. J., Küsters, B., Verrijp, K., Maass, C., Wesseling, P., Heerschap, A., Ruiter, D., Ryan, A., & de Waal, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0823 · Cited by 231
Shukla, S., Robey, R. W., Bates, S. E., & Ambudkar, S. V. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024612 · Cited by 225
Amin, D. N., Hida, K., Bielenberg, D. R., & Klagsbrun, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3387 · Cited by 220
Self-citationXiong, Y.-Q., Sun, H.-C., Zhang, W., Zhu, X.-D., Zhuang, P.-Y., Zhang, J.-B., Wang, L., Wu, W.-Z., Qin, L.-X., & Tang, Z.-Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2780 · Cited by 214
Brendel, C., Scharenberg, C., Dohse, M., Robey, R. W., Bates, S. E., Shukla, S., Ambudkar, S. V., Wang, Y., Wennemuth, G., Burchert, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404638 · Cited by 200
Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
Akino, T., Hida, K., Hida, Y., Tsuchiya, K., Freedman, D., Muraki, C., Ohga, N., Matsuda, K., Akiyama, K., Harabayashi, T., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090202 · Cited by 183
Self-citationJanz, M., Harbeck, N., Dettmar, P., Berger, U., Schmidt, A., Jürchott, K., Schmitt, M., & Royer, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.1610 · Cited by 182
Lu, C., Bonome, T., Li, Y., Kamat, A. A., Han, L. Y., Schmandt, R., Coleman, R. L., Gershenson, D. M., Jaffe, R. B., Birrer, M. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3700 · Cited by 182
Naito, H., Kidoya, H., Sakimoto, S., Wakabayashi, T., & Takakura, N. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.465 · Cited by 173
Heterogeneity of Tumor Endothelial Cells
Ohga, N., Ishikawa, S., Maishi, N., Akiyama, K., Hida, Y., Kawamoto, T., Sadamoto, Y., Osawa, T., Yamamoto, K., Kondoh, M., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.035 · Cited by 166
Self-citationYB‐1 is upregulated during prostate cancer tumor progression and increases P‐glycoprotein activity
Giménez‐Bonafé, P., Fedoruk, M. N., Whitmore, T. G., Akbari, M., Ralph, J. L., Ettinger, S., Gleave, M. E., & Nelson, C. C. (2004) · The Prostate · doi:10.1002/pros.20023 · Cited by 165
A New Perspective on Tumor Endothelial Cells: Unexpected Chromosome and Centrosome Abnormalities
Hida, K., & Klagsbrun, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0002 · Cited by 160
Self-citationAkiyama, K., Ohga, N., Hida, Y., Kawamoto, T., Sadamoto, Y., Ishikawa, S., Maishi, N., Akino, T., Kondoh, M., Matsuda, A., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.029 · Cited by 154 · cited 3×
“Similarly, MDR1/P-glycoprotein upregulation may constitute an important mechanism in drug resistance in TECs (45).”
BackgroundInfluentialSelf-citationAngiogenesis Assays: Problems and Pitfalls
Auerbach, R., Akhtar, N., Lewis, R. L., & Shinners, B. L. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026574416001 · Cited by 141
Isolated tumor endothelial cells maintain specific character during long-term culture
Matsuda, K., Ohga, N., Hida, Y., Muraki, C., Tsuchiya, K., Kurosu, T., Akino, T., Shih, S., Totsuka, Y., Klagsbrun, M., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.089 · Cited by 137
Self-citationVascularization of cutaneous melanoma involves vessel co‐option and has clinical significance
Döme, B., Paku, S., Somlai, B., & Tímár, J. (2002) · The Journal of Pathology · doi:10.1002/path.1124 · Cited by 124
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
Kesari, S., Schiff, D., Doherty, L., Gigas, D. C., Batchelor, T. T., Muzikansky, A., O'Neill, A., Drappatz, J., Chen-Plotkin, A. S., Ramakrishna, N., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-006 · Cited by 122
Shaked, Y., & Kerbel, R. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0905 · Cited by 112
Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
Patel, N., Chatterjee, S. K., Vrbanac, V. D., Chung, I., Mu, C. J., Olsen, R. R., Waghorne, C. G., & Zetter, B. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910649107 · Cited by 106
Ohga, N., Hida, K., Hida, Y., Muraki, C., Tsuchiya, K., Matsuda, K., Ohiro, Y., Totsuka, Y., & Shindoh, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01255.x · Cited by 92
Self-citationAlavi, A. S., Acevedo, L., Min, W., & Cheresh, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3648 · Cited by 89
Isolation and characterization of human breast tumor-derived endothelial cells
Grange, C., Bussolati, B., Bruno, S., Fonsato, V., Sapino, A., & Camussi, G. (2006) · Oncology Reports · doi:10.3892/or.15.2.381 · Cited by 78
Barančı́k, M., Boháčová, V., Sedlák, J., Sulová, Z., & Breier, A. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.08.006 · Cited by 77
Drug resistance associated with antiangiogenesis therapy
Eikesdal, H. P., & Kalluri, R. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.006 · Cited by 74
Eikesdal, H. P., Sugimoto, H., Birrane, G., Maeshima, Y., Cooke, V. G., Kieran, M. W., & Kalluri, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807055105 · Cited by 68
Hida (2010) · International Journal of Oncology · doi:10.3892/ijo_00000622 · Cited by 50
Zhang, Y., Qu, X., Hu, X., Yang, X., Hou, K., Teng, Y., Zhang, J., Sada, K., & Liu, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2533 · Cited by 48
HUANG, X., Ushijima, K., KOMAI, K., TAKEMOTO, Y., Motoshima, S., Kamura, T., & Kohno, K. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.040 · Cited by 41
Krzyzanowska, M. K., Tannock, I. F., Lockwood, G. A., Knox, J. J., Moore, M. J., & Bjarnason, G. A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0347-x · Cited by 39
Mehta, R. S., Jackson, D., & Schubbert, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.9377 · Cited by 10
Research works printed but not linked: 2
- 2004, Clinical Cancer Research, 15, 6222
- Grange, 2006, Oncology reports, 15, 381
Cited by
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Targeting the tumor stroma for cancer therapy
Xu, M., Zhang, T., Xia, R., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01670-1 · Cited by 319
Kareva, I., Waxman, D. J., & Lakka Klement, G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.12.039 · Cited by 249
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Metadata
- Authors
- Hida, K., Akiyama, K., Ohga, N., Maishi, N., & Hida, Y.
- Affiliations
- Hokkaido University (JP)
- Corresponding author
- Hida, K.
- Venue
- Journal of Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-03
- Volume
- 153
- Issue
- 3
- Pages
- 243-249
- ISSN
- 0021-924X (ISSN-L)
- OpenAlex
- W2151576046
- Semantic Scholar
- 4c3a45115bfa8bfe60eb8df9b13a676b29cfa83a
- Cited by
- 68
- References
- 70
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 10 · 2013: 6
- FWCI
- 0.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (21659458, 23390457, 24791958, 24890007, 23890009)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor endothelial cells, drug resistance, multidrug resistance 1, P-glycoprotein, paclitaxel, vascular endothelial growth factor, tumor microenvironment, anti-angiogenic therapy, tumor angiogenesis
- MeSH terms
- Humans, Models, Genetic, Neoplasms, Neovascularization, Pathologic, Gene Expression Regulation, Neoplastic, ATP Binding Cassette Transporter, Subfamily B, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1, Vascular Endothelial Growth Factor A, Endothelial Cells, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.